Inflammatory Bowel Disease and Gut Microbiota

Current Strategies and Future Prospects in Nanomedicine
Herausgeber: Mishra, Neeraj; Garg, Ashish; Ashique, Sumel

• Gebundenes Buch

Produktbeschreibung

Covers novel methodologies and innovative approaches in treatment of IBD. Investigates IBD and significance of gut microbiota in progression of IBD. Investigates microbial imbalances and consequences of restoring microbial homeostasis as treatment. Explores nanotechnology and nanomedicine as treatment as well as future expansions.

Produktdetails

• Verlag: Apple Academic Press
• Seitenzahl: 614
• Erscheinungstermin: 15. Juli 2025
• Englisch
• Abmessung: 240mm x 161mm x 37mm
• Gewicht: 1077g
• ISBN-13: 9781774919361
• ISBN-10: 1774919362
• Artikelnr.: 73390513

Autorenporträt

Neeraj Mishra, PhD, is a Professor at the Amity Institute of Pharmacy, Gwalior, India. He has 20 years of teaching and research experience. A brand ambassador at Bentham Science, he has published more than 100 papers on recent concepts of novel drug delivery systems, oral delivery of synbiotics, localized drug delivery, targeted and controlled drug delivery of nanocarriers/microparticles for the treatment of breast and colon cancer, and neurodegenerative disorders. He has also written more than 15 books and 25 book chapters and has been granted several patents. He was a recipient of an Indian Council of Medical Research Senior Research Fellowship and a Distinguished Professor Award from the Indian Department of Science and Technology, National Science and Technology Management Information System, Synergizing Pharma Academic-Industry Collaboration Systems. Sumel Ashique, MPharm, is a Research Scholar at the School of Pharmaceutical Sciences at Lovely Professional University, Punjab, India, where he is pursuing his PhD. His research area is probiotics, postbiotics, gut microbiota, and inflammatory disorders. With knowledge in drug delivery, nanotechnology, and targeted treatment strategy, he has four years of teaching experience and has published book chapters with international publishers and over 100 papers in accredited reputed journals. He has also six granted intellectual property (IP) patents from IP India and Australia. He is currently editing 13 books with Apple Academic Press, CRC Press, Taylor and Francis, and others. Ashish Garg, PhD, is a Professor at the Guru Ramdas Khalsa Institute of Science and Technology (Pharmacy), Jabalpur, M.P., India. He has around ten years of teaching and research experience and has 80 publications in national and international journals of repute. He has authored 27 book chapters and edited several books on recent concepts of nanotechnology, novel drug delivery systems, cancer targeting, etc. Dr. Garg has been granted three international patents and has published three Indian patents. He also acts as an editorial board member and reviewer for several journals.

Inhaltsangabe

1. Introduction to Gut Microbiota and Inflammatory Bowel Disease: A
Systematic Review 2. Pathogenesis of Gut Microbiota in Inflammatory Bowel
Disease 3. Impact of Nutraceuticals on Gut Microbiota for the Management of
Inflammatory Bowel Disease 4. Targeting Gut Microbiota with a Novel Drug
Delivery System to Treat Inflammatory Bowel Disease 5. Management of Gut
Microbiota-Derived Bacterial Metabolites Induced Inflammatory Bowel Disease
6. Correlation Between Host Genetics and Gut Microbiota in Inflammatory
Bowel Disease 7. Oral siRNA-Based Nanomedicine for the Treatment of
Inflammatory Bowel Disease 8. Site-Specific Targeted Novel Drug Delivery
System for the Management of Inflammatory Bowel Disease 9. Surface-Modified
Lipid Nanoparticle-Mediated Site-Specific Drug Delivery for Inflammatory
Bowel Disease 10. Interplay Between Autophagy, Gut Microbiota, and
Inflammatory Bowel Disease 11. Role of Reactive Oxygen Species, Superoxide
Dismutases, and Inflammation in Association with Gut Microbiota and
Inflammatory Bowel Disease 12. Composition of Gut Microbiota Dysbiosis and
Functional Food to Treat Inflammatory Bowel Disease 13. Age-Related Gut
Dysbiosis and Its Impact on Inflammatory Bowel Disease 14. Impact of
Diseased Condition on Gut Microbiota in Inflammatory Bowel Disease 15. Role
of Probiotics and Prebiotics in Inflammatory Bowel Disease 16. Application
of Natural Products to Target Gut Microbiota for Inflammatory Bowel Disease
Management 17. Future Prospects and Patents of Nanomedicines in Treating
Inflammatory Bowel Disease